Skip to main content
OpenTrials
Completed

NCT Number: NCT05177354

Medtronic Closed-Loop Spinal Cord Stimulation System

The purpose of the study is to further understand the closed-loop feature in chronically implanted patients by characterizing the efficacy of the next generation, spinal cord stimulator.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sydney Pain Specialists, Bella Vista, New South Wales, Australia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • Candidate is undergoing Medtronic SCS device trial for chronic, intractable pain of the trunk and/or limbs
  • If being treated for low-back and/or leg pain,
  • the baseline overall^ Visual Analog Scale is ≥ 60 mm and
  • baseline back and/or leg pain Visual Analog Scale is ≥60 mm. ^Average overall pain in the back and/or leg in the 72 hours prior to the baseline visit, measured using Visual Analog Scale.
  • If being treated for upper limb pain - baseline Visual Analog Scale is ≥ 60 mm for upper limb pain
  • On stable (no change in dose, route, or frequency) prescribed pain medications being used for back and leg pain or upper limb pain, as determined by the investigator, for at least 28 days prior to device trial
  • Willing and able to provide signed and dated informed consent
  • Willing and able to comply with all study procedures and visits

Exclusion criteria

  • Indicated for an SCS device to treat stable intractable Angina Pectoris or Peripheral Vascular Disease of Fontaine Stage III or higher
  • Previously trialed or implanted with spinal cord stimulator, peripheral or vagus nerve stimulator, deep brain stimulator or an implantable intrathecal drug delivery system
  • Currently participating, or plans to participate, in another investigational study unless written approval is provided by the Medtronic study team
  • Major psychiatric comorbidity or other progressive diseases that may confound study results, as determined by the Investigator
  • Serious drug-related behavioral issues (e.g. alcohol dependency, illegal substance abuse), as determined by the Investigator
  • Pregnant or planning on becoming pregnant (if female and sexually active, subject must be using a reliable form of birth control, be surgically sterile, or be at least 2 years post-menopausal)
  • Be involved in an injury claim or under current litigation

Treatment and study plan

Inceptiv

Device

Implantable Neurostimulator with Neuro Sense

Primary outcomes

  1. Reduction in Overstimulation Sensation

    Time frame: 30 days from device activation

    The primary outcome is the proportion of low-back and/or leg pain subjects whose average overstimulation intensity score with Closed Loop On is less than their average overstimulation intensity score with Closed Loop Off. During in-clinic testing, subjects perform protocol prescribed activities and rate the intensity of the sensations on a 5-point Likert scale with both Closed Loop On and Off. The average overstimulation intensity scores within each subject are calculated separately for Closed Loop On and Off, and the proportion of subjects with a lower average overstimulation intensity score during Closed Loop On compared to their overstimulation intensity score during Closed Loop Off is calculated with a one-sided 97.5% lower bound.

Secondary outcomes

  1. Responder Rate for Treatment of Overall Pain

    Time frame: 3 months from device activation

    Responder rate defined as a reduction in Overall (back/leg) pain VAS of at least 50%.

  2. Responder Rate for Treatment of Low-back Pain

    Time frame: 3 months from device activation

    Responder rate defined as a reduction in back pain VAS of at least 50%.

  3. Responder Rate for Treatment of Leg Pain

    Time frame: 3 months from device activation

    Responder rate defined as a reduction in leg pain VAS of at least 50%.

Sponsors and collaborators

Lead sponsor

MedtronicNeuro

Industry

Registry information

Official study title

Evaluation of Long-term Patient Experience With a Medtronic Closed-Loop Spinal Cord Stimulation System

Important dates

Study start
2021
Primary completion
2023
Study completion
2025
First posted
Jan 4, 2022
Registry last updated
Nov 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.